Research news
The first participant has received either ambroxol or the placebo in the ASPro-PD trial. This marks the start of 330 people with Parkinson’s taking a component of an already approved drug over 2 years to see if it is beneficial.
The National Institute for Health and Care Excellence (NICE) has published new guidelines asking health professionals to address gambling related harms when supporting people with Parkinson’s.
Parkinson’s UK and the UK Dementia Research Institute (UK DRI) join forces to establish a pioneering research centre.
A study predicting health trends worldwide suggests that incidence of Parkinson’s is rising due to an ageing population.
Nearly £600,000 has been awarded to 2 outstanding scientists to develop their Parkinson’s research careers.
The full results show that exenatide had no benefits over the placebo and didn’t slow the progression of Parkinson’s.
The government has announced plans to reform elective (planned) health care in England to reduce waiting lists and give patients more choice, but more is needed for people with Parkinson’s.
A small study of a drug called propranolol looked effective in easing tremor both at rest and in stressful situations for people with Parkinson’s.
We're disappointed that Lecigon, a new treatment for advanced Parkinson's, has been rejected by NHS Scotland. We're increasingly concerned about access to advanced treatments in Scotland.